Live Demo:
This is a live DrugChatter demonstration using real AI-generated drug queries and analysis.
Want to see how your drug is represented by AI?
Contact DrugChatter
ozempic
Brand Visibility Tracking
How this brand shows up in AI chatbot answers — presence, position, sentiment, and how it stacks up against competitors.
–
Score / 100
Latest check
Weighted composite of presence, position, sentiment, and recommendation strength across tracked prompts.
Presence
–
Avg. position
–
Lower is betterSentiment
–
Recommendation mix — latest check
How the brand was framed across the latest tracked prompts.
Competitive landscape — latest check
Visibility vs. sentiment. Bubble size reflects rank position (bigger = higher-ranked).
Best known for — latest check
Core Claims — latest check
Ozempic is approved for type 2 diabetes and is typically dosed and titrated to achieve blood-sugar control.
Ozempic and Wegovy are related but not the same medicine.
They use the same drug (semaglutide), but they’re formulated and prescribed for different purposes with different titration/dosing targets.
Differentiators — latest check
Same active ingredient: semaglutide.
Different FDA-approved use and dosing approach.
Different dosing products (pens) and not interchangeable at the same dose.
Competitor comparison — latest check
| Brand | Visibility | Sentiment | Position | Recommended |
|---|
30-day composite trends
Score
Overall composite score, per day.
Visibility vs. sentiment
Two lenses on the same conversations — how much the brand shows up, and how it's spoken about.
Average rank position
Where the brand lands among all brands mentioned, in reading order. Lower is better.
Recent checks
| Date | Score | Visibility | Position | Sentiment |
|---|---|---|---|---|
| Sep 5, 2026 | 60 | 59 | 1 | 50 |
| Sep 6, 2026 | 58 | 52 | 1 | 50 |